EGETIS THERAPEUTICS AB financial statements, including revenue, expenses, profit, and loss
The total revenue of EGTX for the last quarter is 32.60 M SEK, and it's 167.21% higher compared to the previous quarter. The net income of Q4 23 is -86.30 M SEK.